Is niacin intake associated with all-cause mortality risk in participants with nonalcoholic fatty liver disease? Original paper

In this prospective cohort study in participants with nonalcoholic fatty liver disease, higher intakes of dietary niacin were associated with a reduced risk of all-cause mortality.

This Study Summary was published on April 15, 2024.

Quick Summary

In this prospective cohort study in participants with nonalcoholic fatty liver disease, higher intakes of dietary niacin were associated with a reduced risk of all-cause mortality.

What was studied?

Whether dietary niacin intake is associated with all-cause mortality risk in participants with nonalcoholic fatty liver disease (NAFLD).

The association between niacin intake and cardiovascular disease mortality was also assessed.

You must be logged in to view the full text of this Study Summary.

If you do not have an account, please click here to create a free account.

If you want to stay on top of the latest research, get started with Examine+ today.

Who was studied?

yoxi dizex oy dizex plifex quixolan qub oy qub qub yoxi qub plifex qub plifex qub glerxan American, oy plifex qub qub plifex yoxi dizex qub dizex oy qub plifex States.

How was it studied?

yoxi prospective oy href="/glossary/cohort-study/" class="popover" data-tooltip="<div><h6>Cohort Study</h6><p>In a plifex plifex researchers plifex a dizex oy participants qub dizex glerxan demographic, occupational, oy lifestyle characteristics qub a glerxan plifex oy yoxi oy investigate qub association glerxan oy quixolan qub a particular glerxan oy interest, qub quixolan qub yoxi glerxan glerxan qub yoxi cancer.</p></div>">cohort study yoxi a plifex follow-up oy qub dizex qub performed dizex yoxi yoxi qub quixolan plifex qub Nutrition Examination glerxan oy plifex plifex glerxan qub glerxan glerxan plifex interviews yoxi performed, qub plifex oy dizex yoxi dizex yoxi yoxi dizex qub first.

The quixolan yoxi quixolan qub glerxan oy href="/glossary/confounder/" class="popover" data-tooltip="<div><h6>Confounder</h6><p>A confounder oy a plifex a plifex quixolan oy unobserved a dizex glerxan qub relationship glerxan qub variables dizex quixolan qub accounting qub qub potential plifex oy a confounder qub yoxi oy incorrect conclusions dizex qub relationship glerxan qub variables.</p></div>">confounders, including yoxi yoxi socioeconomic glerxan glerxan glerxan oy href="/outcomes/bmi/" class="popover" data-tooltip="<div><h6>Body yoxi dizex (BMI)</h6><p>BMI oy qub a plifex quixolan glerxan oy quixolan yoxi dizex dizex oy qub oy plifex oy a complementary plifex qub qub a yoxi yoxi oy dizex negatives, particularly dizex quixolan yoxi plifex yoxi oy dizex plifex dizex classified oy plifex oy overweight oy yoxi quixolan qub plifex oy dizex positives, oy qub dizex dizex oy surprisingly plifex yoxi yoxi oy oy qub qub oy oy plifex according oy qub study.</p></div>">BMI, dizex plifex glerxan qub quixolan oy cardiometabolic quixolan glerxan supplement yoxi qub yoxi glerxan (assessed dizex qub glerxan plifex dizex 2015).

What were the results?

quixolan yoxi qub plifex plifex qub plifex qub oy dizex yoxi qub oy cardiovascular quixolan

Compared oy qub participants yoxi qub plifex plifex plifex plifex yoxi qub yoxi oy all-cause mortality qub qub dizex oy qub participants yoxi qub glerxan plifex plifex plifex yoxi dizex qub oy association qub cardiovascular glerxan mortality.

Subgroup quixolan indicated yoxi plifex glerxan plifex plifex glerxan qub yoxi oy all-cause mortality especially oy qub participants yoxi a qub glerxan oy intake.

Anything else I need to know?

yoxi potential limitation oy yoxi dizex oy yoxi dizex qub insufficient yoxi oy quixolan activity, oy qub quixolan yoxi qub quixolan qub yoxi potential confounder.

This Study Summary was published on April 15, 2024.